P
LMAT icon

&Partners’s LeMaitre Vascular LMAT Stock Holding History

&Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Sell
2,616
-217
-8% -$20.7K ﹤0.01% 2033
2025
Q4 		$230K Buy
2,833
+44
+2% +$3.79K ﹤0.01% 2069
2025
Q3 		$244K Buy
+2,789
New +$249K ﹤0.01% 1851

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

&Partners's LMAT Position: Q1 2026 in Review

&Partners reduced its LeMaitre Vascular (LMAT) stake by 7.7% in Q1 2026, selling an estimated $20.7K and leaving 2,616 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

&Partners first reported a position in LMAT in Q3 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • &Partners held 2,616 shares of LeMaitre Vascular worth $286K as of Q1 2026.
  • &Partners sold 217 LeMaitre Vascular shares in Q1 2026, an estimated $20.7K.
  • LeMaitre Vascular made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #2033 holding.
  • &Partners first reported a position in LeMaitre Vascular in Q3 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.